Risk Adaption in Clinical Trials of Investigational Medicinal Products (CTIMPs)
MHRA are actively promoting a risk proportionate approach to CTIMPs
GPvP 2018 Symposium - Pre -Symposium Questionnaire
Posted by:
Mandeep Rai and clairelongman, Posted on:
-
Categories:
Events and symposia, Good pharmacovigilance practice
Help us with the key topics you would like to hear about
2018 MHRA Laboratories Symposium
Posted by:
Lynsay Hunter, Posted on:
-
Categories:
Compliance matters, Events and symposia, Good clinical practice, Good laboratory practice, Good manufacturing practice
The Inspectorate laboratories group conducts a diverse number of inspections both internationally and across the United Kingdom.
EU-FDA mutual recognition of inspections of medicines manufacturers enters operational phase
Posted by:
Ian Rees and Mark Birse, Posted on:
-
Categories:
Compliance matters, Good clinical practice, Good distribution practice, Good laboratory practice, Good manufacturing practice
Today marks the start of the operational phase of the EU-FDA mutual recognition agreement
Related content and links
Recent Comments